Search
Check Out Our Sponsors
Latest topics
Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling
Page 1 of 1
Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling
Abstract
For some years now, reduced testosterone levels have been related to obesity, insulin resistance, type 2 diabetes, heart disease, benign prostatic hypertrophy and even prostate cancer – often considered guilty more by association, than actual cause – with little attention paid to the important role of increased intracellular oestrogen, in the pathogenesis of these chronic diseases.
In the final stage of the steroidogenic cascade, testosterone is metabolised to oestradiol by P450 aromatase, in the cytoplasm of adipocytes, breast cells, endothelial cells and prostate cells, to increase intracellular oestradiol concentration at the expense of testosterone.
It follows therefore, that any compound that up-regulates aromatase, or any molecule that mimics oestrogen, will not only increase the activation of the mainly proliferative, classic ER-α, oestrogen receptors to induce adipogenesis and growth disorders in oestrogen-sensitive tissues, but also activate the recently identified transmembrane G protein-coupled oestrogen receptors (GPER), and deleteriously alter important intracellular signalling sequences, that promote mitogenic growth and endothelial damage.
This paper simplifies how stress, xeno-oestrogens, poor dietary choices and reactive toxins up-regulate aromatase to increase intracellular oestradiol production; how oestradiol in combination with leptin and insulin cause insulin resistance and leptin resistance through aberrant serine phosphorylation; how the increased oestradiol, insulin and leptin stimulate rapid, non-genomic G protein-coupled phosphorylation cascades, to increase fat deposition and create the vasoconstrictive, dyslipidemic features of metabolic syndrome; how aberrant GPER signalling induces benign prostatic hypertrophy; and how increased intracellular oestradiol stimulates mitogenic change and tumour-cell activators, to cause prostate cancer.
In essence, the up-regulation of aromatase produces increased intracellular oestradiol, increases ER-α activation and increases GPER activation, in combination with insulin, to cause aberrant downstream transduction signaling, and thus induce metabolic syndrome and mitogenic prostate growth.
To understand this fact, that raised intracellular oestradiol levels in men, induce and promote obesity, gynecomastia, metabolic syndrome, type two diabetes, benign prostatic hypertrophy and prostate cancer, rather than low testosterone, represents a shift in medical thinking, a new awareness, that will reduce the rising incidence of obesity, metabolic syndrome and prostate disease, and significantly improve the health of men worldwide.
Highlights
► Do raised intracellular oestrogens in men contribute to adversely affect men’s health? ► Aromatase in oestrogen-sensitive tissues converts testosterone to oestradiol. ► Stress, poor dietary habits and xeno-oestrogens up-regulate aromatase. ► The resultant raised intracellular oestrogens activate proliferative ER-α and GPER’s. ► Aberrant signaling by oestrogens and insulin induce metabolic syndrome and prostate disease in men.
https://www.sciencedirect.com/science/article/abs/pii/S0303720711007441
For some years now, reduced testosterone levels have been related to obesity, insulin resistance, type 2 diabetes, heart disease, benign prostatic hypertrophy and even prostate cancer – often considered guilty more by association, than actual cause – with little attention paid to the important role of increased intracellular oestrogen, in the pathogenesis of these chronic diseases.
In the final stage of the steroidogenic cascade, testosterone is metabolised to oestradiol by P450 aromatase, in the cytoplasm of adipocytes, breast cells, endothelial cells and prostate cells, to increase intracellular oestradiol concentration at the expense of testosterone.
It follows therefore, that any compound that up-regulates aromatase, or any molecule that mimics oestrogen, will not only increase the activation of the mainly proliferative, classic ER-α, oestrogen receptors to induce adipogenesis and growth disorders in oestrogen-sensitive tissues, but also activate the recently identified transmembrane G protein-coupled oestrogen receptors (GPER), and deleteriously alter important intracellular signalling sequences, that promote mitogenic growth and endothelial damage.
This paper simplifies how stress, xeno-oestrogens, poor dietary choices and reactive toxins up-regulate aromatase to increase intracellular oestradiol production; how oestradiol in combination with leptin and insulin cause insulin resistance and leptin resistance through aberrant serine phosphorylation; how the increased oestradiol, insulin and leptin stimulate rapid, non-genomic G protein-coupled phosphorylation cascades, to increase fat deposition and create the vasoconstrictive, dyslipidemic features of metabolic syndrome; how aberrant GPER signalling induces benign prostatic hypertrophy; and how increased intracellular oestradiol stimulates mitogenic change and tumour-cell activators, to cause prostate cancer.
In essence, the up-regulation of aromatase produces increased intracellular oestradiol, increases ER-α activation and increases GPER activation, in combination with insulin, to cause aberrant downstream transduction signaling, and thus induce metabolic syndrome and mitogenic prostate growth.
To understand this fact, that raised intracellular oestradiol levels in men, induce and promote obesity, gynecomastia, metabolic syndrome, type two diabetes, benign prostatic hypertrophy and prostate cancer, rather than low testosterone, represents a shift in medical thinking, a new awareness, that will reduce the rising incidence of obesity, metabolic syndrome and prostate disease, and significantly improve the health of men worldwide.
Highlights
► Do raised intracellular oestrogens in men contribute to adversely affect men’s health? ► Aromatase in oestrogen-sensitive tissues converts testosterone to oestradiol. ► Stress, poor dietary habits and xeno-oestrogens up-regulate aromatase. ► The resultant raised intracellular oestrogens activate proliferative ER-α and GPER’s. ► Aberrant signaling by oestrogens and insulin induce metabolic syndrome and prostate disease in men.
https://www.sciencedirect.com/science/article/abs/pii/S0303720711007441
Cat with a Hat- Posts : 75
Join date : 2019-08-19
Similar topics
» The association of insulin resistance and metabolic syndrome in early androgenetic alopecia.
» Burden of infection on Insulin Resistance, Metabolic Syndrome, Thyroid, Stress, and Inflammation
» Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study.
» The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
» Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics
» Burden of infection on Insulin Resistance, Metabolic Syndrome, Thyroid, Stress, and Inflammation
» Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study.
» The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
» Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Yesterday at 4:25 am by shaftless
» Is it possible that testosterone levels have to be kept within a strict range?
Mon Mar 25, 2024 3:08 am by Jean-Guy
» I am trying the Growband
Mon Mar 25, 2024 2:57 am by Jean-Guy
» Hydrocurc
Mon Mar 25, 2024 2:48 am by Jean-Guy
» questions about HGH
Mon Mar 25, 2024 1:24 am by Dudard
» The Vital Role of NAD+ and Niacin in Longevity and Well-being
Sat Mar 23, 2024 10:25 am by CausticSymmetry
» solar eclipse on april 8
Sat Mar 23, 2024 1:53 am by shaftless
» Ways to increase adult stem cells
Fri Mar 22, 2024 4:15 pm by Atlas
» How to increase FGF9
Fri Mar 22, 2024 3:17 am by Atlas